In APOE4 carriers, cholesterol may be directly causal in both Alzheimer’s and Parkinson’s disease. A new study demonstrates mechanistically that the over-accumulation of cholesterol in astrocytes (support cells in the brain) ultimately leads to the generation of toxic proteins like alpha-synuclein and amyloid, which are hallmarks of these diseases.
Link to article:
mountsinai.orgMount sinai researchers identify how apoe4 gene damages brain blood vessels in alzheimers diseasemountsinai.orgQuoted:
Experiments showed that APOE4 causes cholesterol to accumulate in astrocytes, support cells with essential roles in maintaining brain health. This excess cholesterol impairs the astrocytes' lysosomal waste-disposal system, reducing their ability to break down alpha-synuclein. The protein instead aggregates and spreads to neurons, leading to harmful protein deposits. The findings identify cholesterol metabolism in astrocytes and lysosomal function as promising therapeutic targets for Alzheimer's and Parkinson's disease.
The miBrain model allowed researchers to study, in complex human brain-like tissue, how genetic risk factors such as APOE4 promote the buildup of harmful proteins associated with neurodegenerative disease. The researchers identified a chain of events linking APOE4 to lipid [cholesterol] accumulation in astrocytes, impaired clearance of alpha-synuclein, and toxic protein deposits, pointing to lipid metabolism and cellular waste-removal pathways as potential therapeutic targets.
Note:
In a second study, the researchers also discovered how APOE4 damages the microvasculature supplying blood to white matter, via mechanisms unrelated to cholesterol.
#apoe4HD #microvasculatureHD #alzheimersHD #parkinsonsHD #cholesterolHD #brainHD #alphasynucleinHD #lewybodydementiaHD


